Health Care

Medical device maker Abbott Laboratories (NYSE: ABT) on Thursday reported a 4% increase in sales for the fourth quarter of…

Essity Aktiebolag (STO: ESSITYB) on Thursday reported its full-year 2025 financial results, highlighting a period of increased profitability and market…

Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2025 earnings results today. Reported sales increased 9.1% year-over-year to $24.56…

Johnson & Johnson’s JNJ.N shares were trading around $218.21, down about 0.2 percent intraday on Wednesday, extending recent modest weakness…

Johnson & Johnson (NYSE: JNJ) is capitalizing on its transition from a broad-based healthcare conglomerate into a market leader in…

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of…

IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance.…

Pfizer Inc. (NYSE: PFE) has reaffirmed its earnings outlook for fiscal 2025 and revised revenue guidance. The pharma giant also…

After a modest start to the year, IPO activity rebounded in the second half of the year as recession fears…

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with…